Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
5-day change
1st Jan Change
5,775
JPY
+1.57%
+7.50%
+6.16%
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million
November 13, 2023 at 01:51 am EST
TOKYO (Reuters) - Japan's Ajinomoto said on Monday it agreed to acquire U.S.-based genetic medicines maker Forge Biologics Holdings for 82.8 billion yen ($546 million).
The transaction is expected to be completed in December 2023 pending regulatory approvals, Ajinomoto said a release.
($1 = 151.7400 yen)
(Reporting by Mariko Katsumura and Rocky Swift in Tokyo; Editing by Tom Hogue)
Transcript : Ajinomoto Co., Inc. - Analyst/Investor Day
Mar. 26
TechMagic, Inc. announced that it has received funding from a group of investors
Mar. 26
CI
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Mar. 26
CI
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots
Mar. 12
MT
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
Mar. 08
CI
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.
Mar. 06
CI
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors
Feb. 20
CI
Transcript : Ajinomoto Co., Inc., Q3 2024 Earnings Call, Feb 06, 2024
Feb. 06
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.
Jan. 30
CI
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research
Jan. 17
MT
Ribomic Enters Into Drug Research Collaboration with Ajinomoto
Jan. 17
MT
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement
Jan. 16
CI
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
Jan. 05
CI
Transcript : Ajinomoto Co., Inc. - Special Call
Dec. 04
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million
Nov. 13
RE
Ajinomoto Co., Inc. announces an Equity Buyback for 10,000,000 shares, representing 1.92% for ¥40,000 million.
Nov. 13
CI
Ajinomoto Co., Inc. authorizes a Buyback Plan.
Nov. 12
CI
China Trade Report, Wall Street Cues Blunt Asian Stock Markets
Nov. 07
MT
Japan's Nikkei falls after sharp gains, Treasury yields rise weighs
Nov. 06
RE
Transcript : Ajinomoto Co., Inc., Q2 2024 Earnings Call, Nov 07, 2023
Nov. 06
Transcript : Ajinomoto Co., Inc., Q2 2024 Earnings Call, Nov 06, 2023
Nov. 06
Transcript : Ajinomoto Co., Inc. - Analyst/Investor Day
23-09-04
Transcript : Ajinomoto Co., Inc., Q1 2024 Earnings Call, Aug 04, 2023
23-08-04
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on May 11, 2023.
23-08-01
CI
Ajinomoto Co., Inc.'s Equity Buyback announced on May 11, 2023, has expired with 9,691,800 shares, representing 1.84% for ¥49,999.89 million.
23-07-30
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Ajinomoto Co., Inc. specializes in the production and marketing of food and pharmaceutical products. Net sales break down by activity as follows:
- sale of food products (57%): seasonings (brands AJI-No-Moto and Hon-Dashi), mayonnaise (Pure Select), instant noodles, beverages, etc.;
- sale of frozen products (19.7%);
- other (23.3%).
More about the company
Last Close Price
5,775
JPY
Average target price
5,989
JPY
Spread / Average Target
+3.71%
Consensus
1st Jan change
Capi.
+6.16% 18.86B -4.93% 261B -2.51% 94.98B +3.19% 46.39B +8.74% 39.99B -0.15% 38.02B -16.78% 30.16B -6.61% 28.72B +11.32% 24.54B -9.29% 22.65B
Other Food Processing
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
AJINOMOTO CO., INC. 
